검색어 : 통합검색[006.6]
총 4,141건 중 1,000건 출력
, 23/100 페이지
-
221
- Protection against toxic amyloid-beta oligomers by PMN310, a monoclonal antibody rationally designed for greater therapeutic potency in Alzheimer’s disease (P1-6.006)
- Kaplan, Johanne; Gibbs, Ebrima; Silverman, Judith; Zhao, Beibei; Coutts, Juliane; Peng, Xubiao; Plotkin, Steven; Cashman, Neil; ProMIS Neurosciences; University of British Columbia; University of British Columbia; University of British Columbia; UBC; University of British Columbia; University of British Columbia; University of British Columbia; (Neurology, v.100, 2023, pp.4597)
-
222
- P.6.d.006 I was gonna process rewards - but then I got high: the acute and chronic effects of cannabis and ketamine on reward processing
- Lawn, W.; Freeman, T.; Pope, R.; Joyce, A.; Harvey, L.; Hindocha, C.; Mokrysz, C.; Moss, A.; Das, R.; Curran, H.; ; (European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, v.25, 2015, pp.S614-S615)
-
223
- Manuel Belda, Guiados por el Espíritu de Dios. Curso de Teología espiritual, Palabra («Colección Pelícano»), Madrid 2006, 366 pp., 17 x 24, ISBN 84-9840-006-6.
- Marti-del-Moral, Pablo; ; (Scripta theologica, v.39, 2007, pp.925-930)
-
224
- Differences in Connectivity among the Basal Ganglia, Cerebellum, and Supplementary Motor Area in Parkinson's Disease and Healthy Controls during Predictive Motor Timing (IN6-1.006)
- Bares, M.; Husarova, I.; Mikl, M.; Lungu, O.; Marecek, R.; Vanicek, J.; ; (Neurology, v.78, 2012, pp.IN6-1.006-IN6-1.006)
-
225
- A 5-HT6 Antagonist as Adjunctive Therapy to Cholinesterase Inhibitors in Patients with Mild-to-Moderate Alzheimer’s Disease: Idalopirdine in Phase III (PL02.006)
- Atri, Alireza; Tong, Gary; Isojarvi, Jouko; Odergren, Tomas; California Pacific Medical Center Research Institute San Francisco CA United States; Lundbeck LLC Deerfield IL United States; Lundbeck Deerfield IL United States; H. Lundbeck A/S Valby Denmark; (Neurology, v.86, 2016, pp.PL02.006)
-
226
- An Unusual Case of Transverse Myelitis After Anti-CD19 CAR T Cell Therapy for a Patient with Diffuse Large B Cell Lymphoma (P6-5.006)
- Khanli, Hadi Mohammad; City of Hope National Cancer Center; (Neurology, v.102, 2024, pp.2513)
-
227
- Baseline Serum Neurofilament Light Chain Levels Predict Future Disease Activity Irrespective of Race/Ethnicity: Results from the Phase 3 ASCLEPIOS I/II Trials (P9-6.006)
- Freeman, Jason; Delgado, Silvia; Alvarez, Enrique; Thouvenot, Eric; Okai, Annette; Bhatt, Alit; Wei, Wenjia; Ziemssen, Tjalf; Novartis Pharmaceuticals, USCDMA; Department of Neurology, University of Miami Miller School of Medicine; University of Colorado School of Medicine; Department of Neurology, CHU Nî mes, Univ Montpellier; North Texas Institute of Neurology and Headache; Novartis Healthcare Pvt. Ltd.; Novartis Pharma AG; Department of Neurology, University Clinic Carl-Gustav Carus; (Neurology, v.102, 2024, pp.5349)
-
228
- Emergent Comorbid Events in First Year of Immunomodulatory Treatment in Adults With Generalized Myasthenia Gravis treated in a Neurology Clinic: A Retrospective Review (P6-13.006)
- Katyal, Nakul; Narula, Naureen; Govindarajan, Raghav; University of Missouri-Healthcare; Pulmonary and Critical Care Medicine, Staten Island University Hospital; University of Missouri; (Neurology, v.98, 2022, pp.198)
-
229
- P.6.006 Effects of early parental seperation due to divorce on young adults — assessment of the hypothalamic-pituitary-adrenal axis using the corticotropin releasing hormone stimulation test
- Bloch, M.; Peleg, I.; Koren, D.; Klein, E.; ; (European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, v.13, 2003, pp.S429-S429)
-
230
- 6-month Real-world Effectiveness of Fremanezumab in Patients with Migraine who Switched from Another mAb Targeting the CGRP Pathway (Subgroup Analysis from FINESSE) (P4-12.006)
- Straube, Andreas; Brö ssner, Gregor; Gaul, Charly; Hamann, Xenia; Hipp, Joachim; Kraya, Torsten; Neeb, Lars; Department of Neurology, University Hospital LMU Munich; Department of Neurology, Innsbruck Medical University; Headache Center Frankfurt; Teva GmbH; Teva GmbH; Department of Neurology, Hospital Sankt Georg Leipzig gGmbH; Helios Global Health; (Neurology, v.102, 2024, pp.5481)
QUICK MENU
